by iwd | Sep 25, 2024 | Economy
(Reuters) -BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United States, the obesity drug developer said on Wednesday, in a sign of strong demand from investors.Booming demand for Eli Lilly’s Zepbound and...
by iwd | Sep 9, 2024 | Economy
(Reuters) – MBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic disorders, including obesity, said on Monday it was seeking a valuation of up to $482.5 million in its initial public offering in the United States.WHY...
by iwd | Aug 22, 2024 | Economy
(In Aug 15 story, corrects typo in firm name in paragraph 10 to “+” from “&”)By Alden BentleyNEW YORK (Reuters) -U.S. Treasury yields surged on Thursday after strong economic data all but eliminated fears about a hard economic landing and...
by iwd | Aug 19, 2024 | Economy
(Reuters) – Shares of some mpox vaccine and drug developers jumped sharply on Monday in premarket trading, putting them on track to extend gains from last week as concerns over an outbreak of the virus rise.Shares of GeoVax Labs and Tonix Pharmaceuticals led the...
by iwd | Aug 17, 2024 | Economy
By Alden BentleyNEW YORK (Reuters) -U.S. Treasury yields eased on Friday, partly reversing the previous day’s big gains as investors digested data showing a resilient U.S. consumer and inflation trending lower, leaving the Federal Reserve ample scope for a small...
by iwd | Aug 17, 2024 | Economy
(Reuters) – Speculators raised their net short bets on five-year Treasuries to the largest on record in the latest week, while bearish bets on 10-year Treasury futures were the largest since January, according to data by the Commodity Futures Trading Commission...
